London-based PE firm Actis bids for SA Adcock Ingram - report

By bne IntelliNews May 23, 2013

London-based pan-emerging markets private equity firm Actis has made a bid for Adcock Ingram, South Africa's second-biggest pharmaceutical company, Business Day reported, quoting an unnamed source close to the deal. Actis has declined to comment. Earlier this month, Adcock said that it was evaluating non-binding proposals from unnamed bidders that could lead to the acquisition of 100% of the company or a controlling stake in it.

Adcock’s board turned down last month a ZAR 6.2bn (EUR 501.4mn) offer for a 60% stake from South African industrial conglomerate Bidvest Group, saying Bidvest’s proposal was not made correctly. It has not received a new proposal from Bidvest, but Bidvest has said it hoped that Adcock shareholders would be given the opportunity to vote on its previous offer, turning to a potential hostile bid.

JSE-listed Adcock Ingram has been underperforming since 2008, when it was unbundled from South Africa's biggest foods maker Tiger Brands, and analysts have described it as a long-overdue takeover target.

Related Articles

Pioneer Lithium secures uranium prospecting permit in Botswana

Botswana's government has granted a uranium prospecting licence to ASX-listed Pioneer Lithium Limited (Pioneer). The firm said in a release on July 15 that the Botsalano Uranium Project ... more

South Africa's energy minister presents revised plan to achieve 2030 universal electricity access

South Africa’s Electricity and Energy Minister Kgosientsho Ramokgopa has presented a revised plan to achieve energy access for all South Africans by 2030. In his Budget Vote speech at the National ... more

Egypt and Russia sign supplementary agreements to advance El-Dabaa nuclear plant

Egypt and Russia have signed a supplementary intergovernmental agreement to push forward the El-Dabaa nuclear power plant project in Egypt, Al Arabiya reported on July 8, citing a statement from ... more

Dismiss